Deadline: 10-December-2025
The ABTA’s Research Program provides support to both established and new scientists in discovering more about the causes, effects, diagnosis, and treatment of brain tumors.
The grant supports projects focused on Biomarkers of Risk, Disease Burden, and/or Treatment Response, Brain Tumor Biology, Clinical Research, Diagnosis, Drug Delivery, Etiology, Genetics, Imaging, Molecular/Genetic Epidemiology, Novel Therapeutics, and Risk Assessment.
The ABTA Research Collaboration Grant supports collaborative teams of two faculty members from distinct institutions who are conducting high-risk, high-reward studies with the potential to change diagnostic or treatment paradigms for both adult and pediatric brain tumor care.
The program provides up to $200,000 in support over a two-year period, with the goal of fostering team science and accelerating the development of new approaches that can ultimately improve and save the lives of those affected by brain tumors.
The initiative also encourages the participation of investigators from disciplines outside traditional biological sciences, promoting a broader, multi-disciplinary approach. Grant funds may be used for equipment, supplies, travel related to the project, and data management and sharing costs, though indirect costs, tuition, and visa expenses are not permitted.
Applicants must demonstrate that their proposed research integrates basic, translational, clinical, or epidemiological components. Each project must be led by a Lead Principal Investigator and a Co-Principal Investigator from different institutions.
Eligible applicants must hold full-time faculty appointments, possess doctoral degrees, and meet the eligibility criteria outlined by the ABTA. The Lead Institution must be a non-profit organization located in the U.S. or Canada, while the Co-PI institution may be located anywhere in the world, provided both are non-governmental entities.
The Lead PI is required to present project results at the annual ABTA National Conference following the grant’s conclusion. Applicants must also adhere to ABTA’s policies, including those concerning the use of artificial intelligence in grant preparation.
Letters of Intent must include a project title, biosketches for both Lead PI and Co-PI, a letter of support from the Co-PI, and a project narrative of up to three pages detailing the team structure, project description, and anticipated impact on brain tumor diagnosis and treatment.
For more information, visit ABTA.
